Multi-Stage Malaria Vaccine AdFalciVax:
The Union government has granted licences to five Indian firms to manufacture and commercialise AdFalciVax, the country’s first indigenous multi-stage malaria vaccine developed by ICMR.
- It is India’s first indigenous recombinant chimeric multi-stage malaria vaccine designed to block infection and transmission of Plasmodium falciparum, the deadliest malaria parasite.
- Developed by ICMR–Regional Medical Research Centre (RMRC), Bhubaneswar, with support from ICMR–National Institute of Malaria Research (NIMR) and National Institute of Immunology (NII), New Delhi.
- Aim is to prevent infection in individuals and minimise community transmission of malaria, thereby aiding elimination goals.
